Handling Deviations and CAPA in Stability Reports

Applying ICH Q9 for Deviation Risk Assessment in Pharma Stability Studies

Posted on By

In the pharmaceutical industry, not all deviations pose the same threat to product quality, patient safety, or data integrity. A minor oversight during documentation and a temperature excursion in a stability chamber cannot be treated with equal urgency. This is where the principles of ICH Q9 — Quality Risk Management (QRM) — come into play, helping organizations systematically assess, prioritize, and respond to deviations based on risk.
Click to read the full article.

Handling Deviations and CAPA in Stability Reports, Protocols and Reports

Comprehensive Checklist for Reviewing CAPA Records in Stability Reports

Posted on By

Corrective and Preventive Actions (CAPA) form a critical part of pharmaceutical quality systems, especially within the context of stability studies. These actions not only address current deviations but also prevent future occurrences by targeting systemic issues. However, unless thoroughly reviewed, even a well-documented CAPA plan may fall short of regulatory expectations.
Click to read the full article.

Handling Deviations and CAPA in Stability Reports, Protocols and Reports